Skip to content
AwardedSpainGoods

Ravulizumab ostmine

Published
Published 21 February 2025

Overview

Ravulizumab ostmine kuni 31.07.2026 vastavalt reaalsele vajadusele

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
21 February 2025
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
€700,000
Award date
19 February 2025
Winner
  • TAMRO EESTI OÜ

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    21 February 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Ravulizumab ostmine — won by TAMRO EESTI OÜ — Skim